Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
18,748
Total Claims
$988K
Drug Cost
825
Beneficiaries
$1,198
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-15%
Cost per patient vs peers
$1,198 vs $1,411 avg
-3%
Brand preference vs peers
10.3% vs 10.6% avg
Brand vs Generic
Brand: 1,900 claims · $747K
Generic: 16,499 claims · $236K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 137 | $90K |
| Canagliflozin | 85 | $57K |
| Semaglutide | 47 | $56K |
| Budesonide/Formoterol Fumarate | 139 | $54K |
| Empagliflozin | 60 | $53K |
| Rivaroxaban | 81 | $52K |
| Icosapent Ethyl | 97 | $38K |
| Dapagliflozin Propanediol | 49 | $36K |
| Sitagliptin Phosphate | 35 | $34K |
| Linagliptin | 34 | $19K |
| Insulin Glargine,hum.Rec.Anlog | 42 | $17K |
| Mirabegron | 33 | $16K |
| Cyclosporine | 20 | $14K |
| Insulin Aspart Prot/Insuln Asp | 25 | $14K |
| Diclofenac Sodium | 545 | $13K |
Prescribing Profile
Patient Profile
76
Avg Age
59%
Female
2.00
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data